Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. - Wikidata - awgldk - TriplyDB

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

http://www.wikidata.org/entity/Q33276665

about

Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia Community acquired bacterial pneumonia Utility of blood procalcitonin concentration in the management of cancer patients with infections Biomarkers in community-acquired pneumonia: a state-of-the-art review Postviral Complications: Bacterial Pneumonia Tools for outcome prediction in patients with community acquired pneumonia.Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.Serial Procalcitonin as a Predictor of Bacteremia and Need for Intensive Care Unit Care in Adults With Pneumonia, Including Those With Highest Severity: A Prospective Cohort Study Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study.Procalcitonin testing for diagnosis and short-term prognosis in bacterial infection complicated by congestive heart failure: a multicenter analysis of 4,698 cases.Non-infectious mimics of community-acquired pneumonia.How and when to use common biomarkers in community-acquired pneumonia Defining and predicting severe community-acquired pneumonia.Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up New approaches to sepsis: molecular diagnostics and biomarkers.The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia.Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China.Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis.Defining severe pneumonia.Distinguishing malaria from severe pneumonia among hospitalized children who fulfilled integrated management of childhood illness criteria for both diseases: a hospital-based study in Mozambique.Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial Evaluation and significance of C-reactive protein in the clinical diagnosis of severe pneumonia.Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia.Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial Antibiotic Discontinuation Rates Associated with Positive Respiratory Viral Panel and Low Procalcitonin Results in Proven or Suspected Respiratory Infections.Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia.Postobstructive Pneumonia: An Underdescribed Syndrome Usefulness of plasma procalcitonin to predict severity in elderly patients with community-acquired pneumonia.Bacterial complications of respiratory tract viral illness: a comprehensive evaluation.Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.Prognostic value of procalcitonin in hospitalized patients with lower respiratory tract infections Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin.C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies.The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy

P2860

Q21194921-6B1AFF25-0988-479D-AF8F-B57A8C7FDDCE Q22241379-59182894-AC93-4EEE-9A9C-5BE3166DAD52 Q26768122-9A5D140E-1DE3-4418-A7A8-917D9652F8F7 Q27026995-18B36129-2FCC-4A39-83DA-F7C7BB3B9E3E Q29248089-E6E202B2-BA4E-4F07-85DF-1AD7CD13A7A2 Q30240254-C49CACFD-06AB-40B2-B100-21792BDE45DA Q33290142-FD3E60EE-3D9B-408E-875C-F599259E25FE Q33629533-EDC35919-3F42-41DE-9495-CE21742DAEFE Q33709822-86C8EDB3-7624-4A14-B9B6-656C71B11A77 Q33750355-C9BFCBC0-DDB9-42B8-AFB1-9407E6C3D39F Q33792355-0F531B19-A231-41D9-9939-F96EAFA8D0F5 Q33801313-769935FB-9A8E-4628-8388-929D07785EA6 Q33872274-B7C27894-2C3B-4B01-8BEA-4E5CA8CE8D5A Q34026963-13C0311D-4739-4019-BA5A-8988589FAAEB Q34271299-9407A763-8777-4D20-9FED-9921F27842CB Q34303687-72CF98D2-3ED4-43A4-BB8E-DF09CBEF5527 Q34437683-2FD60CDA-5872-43B3-9FB1-2008FF50EB1E Q34802736-34D71851-E2E4-43AA-9437-8571463537FF Q35068408-15B408C3-43C7-46F7-A17F-3A80D69E38F5 Q35110932-66497674-F48A-445D-A1A2-9AF4E20F705F Q35184605-9A48E1DC-E76B-493B-B304-AF83B8221C38 Q35245974-2760C1EC-6122-4376-88FA-9D681B923C92 Q35770965-F5A8339F-F91F-4609-9CAE-FA4D69522C1B Q35803234-4687F0BF-642F-4FD0-B032-A06C7D9F68E4 Q35850294-0AABB766-2A64-4DFA-9F26-BD5DFA86FA1A Q35978983-62A6914E-76B7-43C1-96BF-733990E49705 Q36073414-577F4632-8829-46F3-9C43-10D1C4CE56DF Q36169564-027C0846-DA4D-48D0-851D-BA12F5537D2C Q36281234-DC7B0AB9-0B15-483F-95D5-AF74AB2F8343 Q36667012-69D51220-FD65-4EB4-960B-02179475E8BB Q36715804-8D28A10E-93E0-43EC-A9BF-533F0143E5DE Q36902191-0AB41294-A565-4322-87CC-9FFEB389196A Q36974947-94BFF41C-CFCB-4EBC-B43B-D4BD87BD2E98 Q37063842-95F6C466-7A9D-4673-B502-C295B01549DA Q37084130-9156B26A-FFE0-47FA-AAAD-D7DD0F492FB0 Q37090231-ECE5B3A9-71AE-4C8B-8A00-1A71886D0387 Q37207285-59EFA9CB-166A-41DA-BC64-635A15CC09AE Q37318175-6614D700-9FA1-41C7-95BC-9820B226E103 Q37346889-755C60F1-EAB3-4CAA-99DA-FA27043ED209 Q37357371-C2EA587C-0B6B-47C2-9DA4-EFFB1F7D25DC

P2860

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

http://www.wikidata.org/entity/Q33276665

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@ast

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@en

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@nl

type

label

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@ast

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@en

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@nl

prefLabel

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@ast

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@en

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@nl

P1433

Q33276665-70EEFB0B-318D-4A19-961E-D81327F46017

P1476

Q33276665-50B8712E-F2B0-4B50-97AC-52F95EB467C8

P2093

Q33276665-150CCF23-B4FA-48E2-8548-2B334B1B6B9C

Q33276665-39CF92AC-90CC-414D-AB60-5843A192A0E8

Q33276665-9569CC2D-6355-4D00-9AD7-61D74C7CCB60

Q33276665-ACC6B959-6F74-4FBC-9C19-1E8D20DC805C

Q33276665-D633424F-D894-4F76-A14B-D2854805D184

Q33276665-EB70C2F2-5137-470F-B184-EDC9754EBFD1

P2860

Q33276665-00F3D808-D55F-4F82-B9BF-8634636D4FC3

Q33276665-025A1265-3FA8-4E89-87B6-8CC5A84654EB

Q33276665-04A0C9F1-AE39-4E93-A0E4-513D527412C2

Q33276665-07080B67-F531-446F-ACAD-5015A06DE5C0

Q33276665-0DBA96B6-2FA6-4B6B-B513-C4E5AB1CE957

Q33276665-133101E3-341B-48CA-8CEB-3ADAF33C8B16

Q33276665-258011A0-C936-408B-A847-872A7E2AB319

Q33276665-2EA755E8-C950-492C-857B-B6AC0E07BD50

Q33276665-350B2675-E68E-4886-BE72-8D19F48E4606

Q33276665-357D4B32-ACEB-407D-99A0-4B66C7A94AFA

P2888

Q33276665-27453692-D17D-4D22-A5BB-FBFC25D45079

P304

Q33276665-D8A82935-9C27-4C28-82FA-E2C5DFF07935

P31

Q33276665-9ED137E1-7AF7-447A-B7F9-4C23E718C6E0

P356

Q33276665-84B67AD6-7D46-4AE7-9D6E-6DFCE78FE271

P478

Q33276665-41A88660-79E1-4641-AB43-7A2034FBA98F

P50

Q33276665-1D361CD8-5C30-4ABA-8541-A241403D5E48

Q33276665-50AA0093-4D98-466C-B120-826AE6A3C01F

Q33276665-96E8EE99-BA7D-4914-916C-BA4D6E34F165

P577

Q33276665-ABB066BC-BD75-4C64-A80C-ABA92D55EF0E

P5875

Q33276665-1A8CD636-35E1-45AD-A615-F83F3C7CCA16

P6179

Q33276665-8701A5F7-FDE5-46C1-BC8E-3F384B853DB6

P698

Q33276665-094BE46E-ADB8-4699-835F-DD7A51B14F6E

P921

Q33276665-3258f125-f90b-4a78-8985-3a1ba9f9f09d

Q33276665-9F185CB7-FC83-4D07-B098-038E07364531

P932

Q33276665-A03DA49D-6647-4D8E-AB29-27787023544A

P356

P1433

BMC Infectious Diseases

P1476

Diagnostic and prognostic accu ...... community-acquired pneumonia.

@en

P2093

Beat Müller

http://www.w3.org/2001/XMLSchema#string

Charly Nusbaumer

http://www.w3.org/2001/XMLSchema#string

Christian Mueller

http://www.w3.org/2001/XMLSchema#string

Daiana Stolz

http://www.w3.org/2001/XMLSchema#string

Jörg Leuppi

http://www.w3.org/2001/XMLSchema#string

Michael Tamm

http://www.w3.org/2001/XMLSchema#string

P2860

Pneumonia: update on diagnosis and management

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

Pneumonia in the very old

Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination

A prediction rule to identify low-risk patients with community-acquired pneumonia

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Empirical evidence of design-related bias in studies of diagnostic tests.

Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials.

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

P2888

P304

10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-7-10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Roland Bingisser

Mirjam Christ-Crain

Stephan Harbarth

P577

2007-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6470358

http://www.w3.org/2001/XMLSchema#string

P6179

1011798848

http://www.w3.org/2001/XMLSchema#string

P698

17335562

http://www.w3.org/2001/XMLSchema#string

P921

P932

1821031

http://www.w3.org/2001/XMLSchema#string